PERRIGO COMPANY PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.02 USD | +1.01% |
|
-7.22% | -3.62% |
| 05-07 | Perrigo's Q1 Adjusted Earnings, Net Sales Drop | MT |
| 05-07 | Transcript : Perrigo Company plc, Q1 2024 Earnings Call, May 07, 2024 |
| Sales 2024 * | 4.62B 368B | Sales 2025 * | 4.83B 385B | Capitalization | 4.19B 334B |
|---|---|---|---|---|---|
| Net income 2024 * | -74M -5.9B | Net income 2025 * | 106M 8.44B | EV / Sales 2024 * | 1.6 x |
| Net Debt 2024 * | 3.21B 256B | Net Debt 2025 * | 3.01B 240B | EV / Sales 2025 * | 1.49 x |
| P/E ratio 2024 * |
-21.2
x | P/E ratio 2025 * |
192
x | Employees | 9,140 |
| Yield 2024 * |
3.59% | Yield 2025 * |
3.82% | Free-Float | 99.69% |
More Fundamentals
* Assessed data
More news
Latest transcript on Perrigo Company plc
More recommendations
More press releases
More news
| 1 day | +1.03% | ||
| 1 week | -7.22% | ||
| Current month | -5.04% | ||
| 1 month | +2.94% | ||
| 3 months | -2.35% | ||
| 6 months | +10.14% | ||
| Current year | -3.62% |
1 week
30.08
33.35
1 month
29.7933.46
Current year
25.7734.60
1 year
25.7740.28
3 years
25.7750.90
5 years
25.7763.86
10 years
25.77215.73
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 29/06/23 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 15/05/22 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 14/12/20 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 05/02/17 |
Bradley Alford
BRD | Director/Board Member | 67 | 05/02/17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 18.63% | 13 M€ | -.--% | ||
| 15.31% | 254 M€ | +11.50% | - | |
| 0.66% | 8 M€ | +5.48% | - | |
| 0.46% | 2 M€ | +9.27% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/24 | 31.02 | +0.99% | 138 432 |
| 10/05/24 | 30.71 | -1.00% | 782,730 |
| 09/05/24 | 31.02 | -0.29% | 1,093,712 |
| 08/05/24 | 31.11 | +3.18% | 1,711,065 |
| 07/05/24 | 30.15 | -9.81% | 3,898,066 |
Delayed Quote Nyse, May 13, 2024 at 04:04 pm
More quotes
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Sector
Pharmaceuticals
Calendar
30/05/2024
- Ex-dividend day
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.71
USD
Average target price
39.5
USD
Spread / Average Target
+28.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.62% | 4.19B | |
| +28.95% | 684B | |
| +30.34% | 568B | |
| -3.86% | 361B | |
| +17.80% | 329B | |
| +4.55% | 284B | |
| +16.06% | 240B | |
| +9.33% | 208B | |
| -6.83% | 200B | |
| +7.80% | 166B |
- Stock Market
- Equities
- PRGO Stock
